Barclays Maintains Overweight on Bruker, Raises Price Target to $70

Benzinga Newsdesk www.benzinga.com Positive 85.0%

Neg 0% Neu 0% Pos 85%

Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $58 to $70.